GeneDx
E. Blair Clark-Schoeb currently serves as the Chief Communications Officer at GeneDx, a position held since June 2025. Prior to this role, Clark-Schoeb was the Principal at BiotechComm and previously held the title of Chief Communications Officer at Lykos Therapeutics. Extensive experience includes senior leadership positions in communications at Aruvant and Zyla Life Sciences, as well as ownership of BiotechComm, where strategic and tactical programs were developed for biotech, pharmaceutical, and healthcare businesses. Academic credentials include a Master of Healthcare Innovation from the University of Pennsylvania and a degree from Harvard University.
This person is not in any teams
This person is not in any offices
GeneDx
10 followers
GeneDx is focused on delivering personalized, actionable insights that improve health outcomes. We sit at the intersection of diagnostics and data science, pairing decades of genomic expertise with an unmatched ability to interpret clinical data at scale. Our exome and genome testing is among the best in the industry. We expect that it will be even more advanced in the future with the help of Centrellis®, our innovative health information platform. Powered by millions of medical records, Centrellis® integrates digital tools with artificial intelligence to ingest and synthesize clinical and genomic data. As a result of our robust test menu, including our exome and genome testing, and the comprehensive insights generated by Centrellis®, we are developing a more complete understanding of complex disease than ever before. This translates to faster diagnosis, more effective treatment plans, and enhanced drug discovery. Our offerings help a whole spectrum of healthcare partners -- clinicians, researchers, health systems, pharmaceutical companies, and payors -- improve patient experiences and advance population health.